| Aβ | beta-amyloid peptide |
| N-Acetylserotonin | N-(2-(5-hydroxy-1H-indol-3-yl)ethyl)acetamide |
| AChE | Acetylcholinesterase |
| AD | Alzheimer’s disease |
| Andrographolide | 3-[2-(Decahydro-6-hydroxy-5-hydroxymethyl-5,8a-dimethyl-2-methylene-1-napthalenyl)ethylidene]dihydro-4-hydroxy-2(3H)-furanone |
| Agomelatine | N-[2-(7-Methoxynaphthalen-1-yl)ethyl]acetamide |
| ALS | Amyotrophic lateral sclerosis |
| AR-A014418 | 1-(4-Methoxybenzyl)-3-(5-nitrothiazol-2-yl)urea |
| AREs | Antioxidant response elements |
| BDNF | Brain-derived neurotrophic factor |
| BIO | 6-Bromoindirubin-3’-oxime |
| BrdU | Bromodeoxyuridine |
| BuChE | Butylcholinesterase |
| Buspirone | 8-[4-(4-Pyrimidin-2-ylpiperazin-1-yl)butyl]-8-azaspiro[4,5]decane-7,9-dione |
| CaMKIV | Calcium/calmodulin-dependent protein kinase IV |
| CNS | Central nervous system |
| Curcumin | (1E,6E)-1,7-Bis(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione |
| DG | Dentate gyrus |
| DHEA | Dehydroepiandrosterone |
| ERK | Extracellular signal-regulated kinase |
| Fluoxetine | N-Methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine |
| Fluvoxamine | 2-{[(E)-{5-Methoxy-1-[4-(trifluoromethyl)phenyl]pentylidene}amino]oxy}ethanamine |
| GDNF | Glial cell-derived neurotrophic factor |
| GPCRs | G-protein-coupled receptors |
| GSK-3β | Glycogen synthase kinase-3β |
| HO-1 | Heme oxygenase-1 |
| 5-HT | Serotonin |
| 5-HTRs | Serotonergic receptors |
| Ketanserin | 3-{2-[4-(4-Fluorobenzoyl)piperidin-1-yl]ethyl}quinazoline-2,4(1H,3H)-dione |
| LTP | Long-term potentiation |
| Luzindole | N-(2-(2-Benzyl-1H-indol-3-yl)ethyl)acetamide |
| MeHg | Methylmercury |
| Melatonin | N-(2-(5-Methoxy-1H-indol-3-yl)ethyl)acetamide |
| 5-MeOT | 5-Methoxytryptamine |
| MTRs | Melatonergic receptors |
| Myristic acid | Tetradecanoic acid |
| NAD | Nicotinamide adenine dinucleotide |
| NAMPT | Nicotinamide phosphoribosyl transferase |
| NE-100 | 4-Methoxy-3-(2-phenylethoxy)-N,N-dipropylbenzeneethanamine |
| NGF | Nerve-growth factor |
| NQO1 | NAD(P)H-quinone oxidoreductase 1 |
| Nrf2 | Nuclear erythroid 2-related factor |
| NSCs | Neural stem-cells |
| OBX | Olfactory bulbectomized (mouse) |
| OGD/R | Oxygen-glucose deprivation/reoxygenation |
| 8-OH-DPAT | 8-Hydroxy-2-(di-n-propylamino)tetralin |
| P7C3 | 1-(3,6-Dibromo-9H-carbazol-9-yl)-3-(phenylamino)propan-2-ol |
| P7C3-A20 | N-(3-(3,6-Dibromo-9H-carbazol-9-yl)-2-fluoropropyl)-3-methoxyaniline |
| Pinoline | 6-Methoxy-1,2,3,4-tetrahydro-9H-pyrido[3,4-b]indole |
| PKB | Protein kinase B |
| Resveratrol | trans-3,5,4′-Trihydroxystilbene |
| Rivastigmine | (S)-3-[1-(Dimethylamino)ethyl]phenyl N-ethyl-N-methylcarbamate |
| S32006 | N-(Pyridin-3-yl)-1H-benzo[e]indole-3(2H)-carboxamide |
| SA-4503 | 1-[2-(3,4-Dimethoxyphenyl)ethyl]-4-(3-phenylpropyl)piperazine |
| SB-415286 | 3-((3-Chloro-4-hydroxyphenyl)amino)-4-(2-nitrophenyl)-1H-pyrrole-2,5-dione |
| SGZ | Subgranular zone |
| σRs | Sigma receptors |
| SSRIs | Selective serotonin reuptake inhibitors |
| SVZ | Subventricular zone |
| Tideglusib | 4-Benzyl-2-(naphthalen-1-yl)-1,2,4-thiadiazolidine-3,5-dione |
| TrkB | Tyrosine receptor kinase |
| Valproate | 2-Propylpentanoate |
| WAY100635 | N-[2-[4-(2-Methoxyphenyl)-1-piperazinyl]ethyl]-N-(2-pyridyl)cyclohexane-carboxamide |